Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asia Spotlight: Improve Quality Or You're Out, Says China FDA Commissioner

Executive Summary

In a rare public speech, China FDA Commissioner Bi Jingquan calls for improved drug quality and an ecosystem to reward high-quality medicines, highlighting the agency’s drive to step up enforcement amid another recent scandal that has revealed broad quality problems.

You may also be interested in...



China Regulatory Shakeup: Top Regulator Out, Commissioner Reprimanded Amid Vaccine Scandal

Amid aftermath of latest vaccine scandal, top officials including China’s drug reform flagbearer are forced to resign, sending shock waves across the industry.

Top 10 Drugs Of 2020: #1 Humira

Top 10 Drugs Of 2020: #2 Keytruda

Topics

Related Companies

UsernamePublicRestriction

Register

PS057054

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel